InvestorsHub Logo
icon url

TalShu

08/13/23 3:05 PM

#413873 RE: Number sleven #413872

NSleven
WOOOW
thank you
icon url

lizzy241

08/13/23 3:11 PM

#413875 RE: Number sleven #413872

Sleven, thanks, that's very impressive findings.
icon url

ramfan60

08/13/23 4:57 PM

#413880 RE: Number sleven #413872

Another great find Slevin..... has Amarin/Mochida/MND 2119 all over it...... I feel a bit relieved.
icon url

Whalatane

08/13/23 7:07 PM

#413882 RE: Number sleven #413872

N7. Have you read this Pharma Japan article

Mochida to Roll Out Once-Daily Epadel on Sept. 12
August 19, 2022

Mochida Pharmaceutical said on August 18 that a new once-daily soft capsule version of its hyperlipidemia drug Epadel (ethyl icosapentate) listed the same day will be available on September 12. The new product, Epadel EM Capsules 2 g, is a…



Why hasn't AMRN jumped on this for the US market ? My guess is that they know the FDA will want an independent clinical trial with US patients .
Minimum would be for the Marine indication ...TG's over 500mg/dl .
So if AMRN was to start tomorrow on this , we are probably looking at 2 yrs from start of trial to final FDA approval for VHTG's ( Marine indication ) and that would really eat into the Cash on Hand .

To then get insurers coverage ( after FDA approval ) the once a day pill would need to price at or below the current generic price for 4 caps of the existing . Which it might be able to do ...but a tell would be the pricing in Japan . What does the new once daily pill cost compared the the old Epadel in Japan ...and how much are they selling ?

Kiwi